Protagenic Therapeutics, Inc.\new Payments of Debt Issuance Costs
Protagenic Therapeutics, Inc.\new (PTIX) reported Payments of Debt Issuance Costs of $27.13 thousand for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-17.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfDebtIssuanceCosts · last filed 2021-05-17
- Protagenic Therapeutics, Inc.\new payments of debt issuance costs for the quarter ending 2021-03-31 was $27.13K.
- Protagenic Therapeutics, Inc.\new payments of debt issuance costs for fiscal 2020 was $104.09K.
| Period end | Payments of Debt Issuance Costs 3 month | Payments of Debt Issuance Costs 12 month |
|---|---|---|
| 2021-03-31 | $27.13K 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $104.09K 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |